Cardiovascular outcomes reported in hemodialysis trials
- O'Lone, Emma
- Viecelli, Andrea K.
- Craig, Jonathan C.
- Tong, Allison
- Sautenet, Benedicte
- Roy, David
- Herrington, William G.
- Herzog, Charles A.
- Jafar, Tazeen
- Jardine, Meg
- Krane, Vera
- Levin, Adeera
- Malyszko, Jolanta
- Rocco, Michael V.
- Strippoli, Giovanni
- Tonelli, Marcello
- Wang, Angela Yee Moon
- Wanner, Christoph
- Zannad, Faiez
- Winkelmayer, Wolfgang C.
- Webster, Angela C.
- Wheeler, David C.
Publication date
June 2018
DOI Publisher
Elsevier BV ISSN
0735-1097 Citation count (estimate)
2Abstract
Patients on long-term hemodialysis are at very high risk for cardiovascular disease but are usually excluded from clinical trials conducted in the general population or in at-risk populations. There are no universally agreed cardiovascular outcomes for trials conducted specifically in the hemodialysis population. In this review, we highlight that trials reporting cardiovascular outcomes in hemodialysis patients are usually of short duration (median 3 to 6\ua0months) and are small (59% of trials have\ua
Add to ORKG